TMEM151A phenotypic spectrum includes paroxysmal kinesigenic dyskinesia with infantile convulsions

Huan Wang1, Pengcheng Huang1, Min Zhu1,2

  • 1Department of Neurology, the First Affiliated Hospital of Nanchang University, Nanchang, 330006, China.

Insights

This study identifies a new TMEM151A gene variant linked to paroxysmal kinesigenic dyskinesia (PKD) and benign familial infantile convulsions (BFIC). The findings expand the known disease spectrum associated with this gene.

Area of Science:

  • Genetics
  • Neurology
  • Molecular Biology

Background:

  • Paroxysmal kinesigenic dyskinesia (PKD) is a neurological disorder characterized by brief, involuntary movements.
  • Benign familial infantile convulsions (BFIC) are a type of epilepsy that typically begins in infancy.
  • The genetic basis for some forms of PKD and BFIC remains incompletely understood.

Purpose of the Study:

  • To investigate the genetic cause of paroxysmal kinesigenic dyskinesia (PKD) with comorbid benign familial infantile convulsions (BFIC) in a multi-generational family.
  • To identify novel genetic variants associated with the PKD-PKD/IC-BFIC disease spectrum.

Main Methods:

  • Whole exome sequencing was performed on affected family members.
  • Co-segregation analysis was used to validate the identified genetic variant.
  • Clinical phenotyping of affected individuals was conducted.

Main Results:

  • A novel heterozygous variant, c.1085A>G, in the TMEM151A gene was identified in affected individuals.
  • This variant co-segregated with the phenotype across three generations.
  • One individual presented with a combined phenotype of PKD and BFIC (PKD/IC).

Conclusions:

  • The TMEM151A gene is implicated in the pathogenesis of paroxysmal kinesigenic dyskinesia (PKD).
  • The findings suggest TMEM151A variants may contribute to a broader disease spectrum including PKD with infantile convulsions (PKD/IC) and BFIC.
  • This study expands the understanding of the genetic underpinnings of movement and seizure disorders.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
239
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
582
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
272